摘要
目的探讨抗缪勒氏管激素(AMH)检测在多囊卵巢综合征(PCOS)诊断中的应用价值。方法选取2019年11月至2021年3月我院PCOS患者85例作为PCOS组,并以1:1配比选取同期健康体检者85例作为健康组,均检测AMH、促卵泡激素(FSH)水平,对比两组检测结果,统计两者检测的诊断阳性率,分析不同AMH水平患者排卵率和妊娠率。结果PCOS组AMH较健康组高(P<0.05);AMH诊断的阳性率91.76%(78/85)较FSH诊断42.35%(36/85)高(P<0.05);AMH水平>13.0ng/mL的排卵率57.69%(15/26)较AMH水平<9.0ng/mL 87.10%(27/31)、9.0~13.0ng/mL 75.00%(21/28)低(P<0.05)。结论AMH水平与PCOS发展存在关联性,且随AMH升高患者排卵率降低,对于评估疾病进展具有重要作用,临床诊断和应用价值高。
Objective To investigate the value of antitube hormone(AMH)in the diagnosis of polycystic ovarian syndrome(PCOS).Methods 85 P COS patients with our November 2019 to March 2021 were selected as PCOS group,and 85 were selected with 1:1 ratio.AMH,follicle-promoting hormone(FSH)level were compared,the diagnostic positive rate,ovulation rate and pregnancy rate of patients with different AMH levels were analyzed.Results The positive rate of high(P<0.05);AMH diagnosis was 91.76%(78/85)in PCOS and 57.69%of 42.35%(36/85)than AMH level<9.0ng/mL 87.10%(27/31),9.0~13.0ng/mL 75.00%(21/28).Conclusion AMH level is associated with PCOS development and decreased ovulation rate in patients with elevated AMH has an important role in the evaluation of disease progression and high clinical diagnosis and application value.
作者
于瑞静
YU Rui-jing(Department of Laboratory,the Third People's Hospital of Henan,Zhengzhou 450000,Henan Province,China)
出处
《罕少疾病杂志》
2022年第9期62-63,共2页
Journal of Rare and Uncommon Diseases
